Presence of taste receptor families in the gastrointestinal mucosa suggests a physiological basis for local and early detection of a meal. We hypothesized that luminal Lglutamate, which is the primary nutrient conferring fundamental umami or proteinaceous taste, influences mucosal defense mechanisms in rat duodenum. We perfused the duodenal mucosa of anesthetized rats with L-glutamate (0.1-10 mM). Intracellular pH (pHi) of the epithelial cells, blood flow, and mucus gel thickness (MGT) were simultaneously and continuously measured in vivo. Some rats were pretreated with indomethacin or capsaicin. Duodenal bicarbonate secretion (DBS) was measured with flow-through pH and CO2 electrodes. We tested the effects of agonists or antagonists for metabotropic glutamate receptor (mGluR) 1 or 4 or calcium-sensing receptor (CaSR) on defense factors. Luminal L-glutamate dose dependently increased pH i and MGT but had no effect on blood flow in the duodenum. L-glutamate (10 mM)-induced cellular alkalinization and mucus secretion were inhibited by pretreatment with indomethacin or capsaicin. L-glutamate effects on pHi and MGT were mimicked by mGluR4 agonists and inhibited by an mGluR4 antagonist. CaSR agonists acidified cells with increased MGT and DBS, unlike Lglutamate. Perfusion of L-glutamate with inosinate (inosine 5Ј-monophosphate, 0.1 mM) enhanced DBS only in combination, suggesting synergistic activation of the L-glutamate receptor, typical of taste receptor type 1. L-leucine or L-aspartate had similar effects on DBS without any effect on pH i and MGT. Preperfusion of L-glutamate prevented acid-induced cellular injury, suggesting that L-glutamate protects the mucosa by enhancing mucosal defenses. Luminal Lglutamate may activate multiple receptors and afferent nerves and locally enhance mucosal defenses to prevent subsequent injury attributable to acid exposure in the duodenum. intracellular alkalinization; mucus secretion; bicarbonate secretion; monosodium glutamate; taste receptor THE DUODENAL MUCOSA HAS multilayered, multistep defense mechanisms to counter mucosal injury attributable to constant exposure to luminal concentrated acid and high PCO 2 attributable to gastric acid and secreted HCO 3 Ϫ (24). These mechanisms coordinately regulate premucosal, mucosal, and submucosal components, including mucus and HCO 3 Ϫ secretion, intracellular pH (pH i ) regulation and cellular buffering, and submucosal neuronal activation and blood flow response. Because duodenal luminal pH rapidly changes between 2 and 7 as a result of the constant mixture of secreted HCO 3 Ϫ with jets of antrally propelled gastric acid, the duodenal mucosa must rapidly adjust its defense mechanisms according to luminal pH (23).
THE DUODENAL MUCOSA HAS multilayered, multistep defense mechanisms to counter mucosal injury attributable to constant exposure to luminal concentrated acid and high PCO 2 attributable to gastric acid and secreted HCO 3 Ϫ (24). These mechanisms coordinately regulate premucosal, mucosal, and submucosal components, including mucus and HCO 3 Ϫ secretion, intracellular pH (pH i ) regulation and cellular buffering, and submucosal neuronal activation and blood flow response. Because duodenal luminal pH rapidly changes between 2 and 7 as a result of the constant mixture of secreted HCO 3 Ϫ with jets of antrally propelled gastric acid, the duodenal mucosa must rapidly adjust its defense mechanisms according to luminal pH (23) .
We have examined the upper gastrointestinal (GI) defense factors in response to luminal acid, using fluorescent microscopy and Doppler flowmetry where epithelial pH i , mucosal blood flow, and mucus gel thickness (MGT), corresponding to mucus secretion rate, are simultaneously measured in the gastroduodenum of living rats (6, 7, 9, 25, 34, 43) . In duodenum, luminal acid is sensed by the "capsaicin pathway," consisting of acid-induced intracellular acidification, H ϩ secretion via the basolateral Na ϩ /H ϩ exchanger-1, activation of capsaicin-sensitive afferent nerves, the release of vasoactive mediators, and an increase of mucosal blood flow and mucus secretion, followed by delayed cyclooxygenase (COX)/prostaglandin (PG)-dependent mucus and HCO 3 Ϫ secretion (24) . These data demonstrate that the duodenal mucosa "tastes" luminal acidity using epithelial ion transporters and neuronal acid sensors. Furthermore, luminal CO 2 is also sensed by the capsaicin pathway, facilitated by epithelial carbonic anhydrases (5, 31) , suggesting that luminal H ϩ and CO 2 provide equivalent acid loads that signal protective effector mechanisms.
Although the five basic tastes (sweet, salty, sour, bitter, and umami) have been recognized for centuries, taste receptor families have only recently been cloned from the lingual taste buds (26) . Of interest, these receptors are also present in the GI tract. In addition to salty taste detected by epithelial Na ϩ channels and sour taste by H ϩ -gated ion channels, a heterodimer of the taste receptor, type 1, member 2 (T1R2) and 3 (T1R3) is a sweet receptor, expressed in the small intestinal mucosa (19, 28, 29) . Bitter taste receptors consisting of the taste receptor, type 2 (T2R) family are expressed in the GI tract (47) . This suggests that the intestinal mucosa, in addition to the tongue, also senses the luminal content to presumably detect nutrients and expel unfavorable substances to maintain physiological processes such as digestion, absorption, secretion, and motility.
The receptor for L-glutamate (L-Glu), the primary nutrient conferring umami taste, is a heterodimer of T1R1 and T1R3 (32, 48) or alternately the metabotropic L-Glu receptor (mGluR) 1 or 4 (15, 44) . These receptors belong to G proteincoupled receptor superfamily. These receptors and their cognate G proteins, ␣-gustducin, are localized in the epithelial cells in the GI tract (28, 29, 38, 40) , suggesting that the mucosa directly taste luminal content to release mediators or conduct the luminal information to internal milieu. Indeed, luminal L-Glu stimulates gastric vagal afferents with release of nitric oxide and 5-hydroxytryptamine (5-HT) with the involvement of 5-HT 3 receptor (46), suggesting a nutrient-sensing pathway for L-Glu in the upper GI tract related to known protective efferent neural circuitry. Thus we hypothesized that luminal L-Glu affects mucosal defense mechanisms via L-Glu receptors in the upper GI tract, similar to the acid-sensing pathways.
Here we show that luminal L-Glu enhances duodenal mucosal defenses mediated via multiple L-Glu receptors and activation of capsaicin and COX/PG pathways and that L-Glu protects the duodenal mucosa from acid-induced injury.
MATERIALS AND METHODS
Chemicals and animals. 2Ј,7Ј-Bis(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF) acid, its acetoxy methyl ester (BCECF-AM), and propidium iodide (PI) were obtained from Molecular Probes (Eugene, OR). Two-micron pink fluorescent microspheres were obtained from Bangs Laboratories (Fishers, IN). VU0155041 (cis-2-[[ (3,5-dichlorophenyl) amino]carbonyl]cyclohexane carboxylic acid) sodium salt was obtained from Tocris Bioscience (Ellisville, MO).
, HEPES and other chemicals were obtained from Sigma Chemical (St. Louis, MO). Krebs solution contained (in mM) 136 NaCl, 2.6 KCl, 1.8 CaCl 2, and 10 HEPES at pH 7.0. Osmolarity was adjusted to isotonic by reducing NaCl concentration. pH of Krebs solution after dissolving the compound was adjusted to pH 7.0. All solutions were prewarmed at 37°C in a water bath, and temperature was maintained by a heating pad. All studies were performed with approval of the Veterans Affairs Institutional Animal Care and Use Committee (VA IACUC). Male Sprague-Dawley rats weighing 200 -250 g (Harlan, San Diego, CA) were fasted overnight but had free access to water.
Measurements of pH i, blood flow, and MGT in duodenum. Simultaneous measurements of pHi of duodenal epithelial cells using fluorescent ratio technique, duodenal blood flow with laser Doppler flowmetry, and MGT with fluorescent microspheres were performed as described elsewhere (7, 9, 30) . Under isoflurane anesthesia (2%), the exposed, chambered duodenal mucosa was incubated with 10 M BCECF-AM in pH 7.0 Krebs buffer for 15 min to load the duodenal epithelial cells. After BCECF loading, fluorescent microspheres diluted to 0.05% wt/vol with prewarmed Krebs buffer were placed over the mucosa to delineate the luminal surface of the gel layer. Blood flow was measured via serosally placed right angle probe with laser Doppler flowmetry (Transonic, Ithaca, NY).
BCECF fluorescence was visualized with 495-and 450-nm excitation and 515-nm emission (green filter set; Chroma, Brattleboro, VT), whereas fluorescent microspheres were visualized with 575-nm excitation and 600-nm emission (red filter set) using a ϫ10 objective mounted on a Zeiss MPS microscope and recorded with a cooled charge-coupled device video camera (Hamamatsu Orca-EN; Hamamatsu USA, Bridgewater, NJ). Images were captured, digitized, recorded, and analyzed using Apple G4 microcomputer and image analysis software (OpenLab; Improvision, Lexington, MA). pH i was calculated from fluorescence intensity ratio and in vitro calibration Fig. 1 . Effect of luminal L-glutamate (L-Glu) on mucosal defense factors in rat duodenum. Intracellular pH (pHi) of epithelial cells, mucus gel thickness, and blood flow were simultaneously measured in vivo using fluorescence microscopy and flowmetry. Luminal perfusion of L-Glu (0.1-10 mM) dose dependently increased pHi (A) and mucus gel thickness (B) but had no effect on duodenal blood flow (C). Each data point represents mean Ϯ SE (n ϭ 6 rats). *P Ͻ 0.05 vs. pH 7.0 Krebs group. curve as previously described (9) . MGT was determined by measuring traveling distance between focal planes of the green fluorescent cell surface and the red fluorescent microspheres using a digital z-axis measuring device (Quick-Check; Metronics, Bedford, NH) (7).
After BCECF was loaded, fluorescent microspheres were applied on the gel surface, and blood flow was stabilized with pH 7.0 Krebs buffer perfusion for ϳ30 min, the time was set as t ϭ 0. The proximal duodenal mucosa was isolated by the chamber and topically perfused, preventing the contamination of pancreatic secretion. The chambered duodenal mucosa was perfused with pH 7.0 Krebs from t ϭ 0 min until t ϭ 10 min (basal period), followed by with pH 7.0 Krebs with or without chemicals from t ϭ 10 min until t ϭ 20 min (challenge period), then with pH 7.0 Krebs from t ϭ 20 min until t ϭ 35 min (recovery period). All measurements were conducted every 5 min.
Measurement of duodenal HCO 3 Ϫ secretion. Duodenal loops were prepared and perfused as previously described (10, 31) . In brief, under isoflurane anesthesia (2%), the proximal duodenal loop (perfused length 2 cm) was perfused with pH 7.0 normal saline by using a peristaltic pump (Fisher Scientific, Pittsburgh, PA) at 1 ml/min. The perfusate was bubbled with 100% O 2 and stirred and warmed at 37°C with a heating stirrer (Barnstead International, Dubuque, IA). The pH of the perfusate was kept constant at pH 7.0 with a pH stat (models PHM290 and ABU901; Radiometer Analytical, Lyon, France). Furthermore, to eliminate the buffer action of agonists or antagonists, which would over-or underestimate the titration volume using pH stat, two sets of flow through pH and CO 2 electrodes (Lazar Research Laboratories, Los Angeles, CA) were connected in the perfusion loop where pH and [CO 2] were simultaneously and continuously measured. Because the input (perfusate) [CO2] is ϳ0, the effluent [CO2] and pH were used to calculate the total CO2 output equivalent to the secreted HCO 3 Ϫ as previously described (10, 31) . To prevent contamination of the perfusate from bile or pancreatic juice, the pancreaticobiliary duct was ligated just proximal to its insertion into the duodenal wall and cannulated with a PE-10 tube to drain the juice. After stabilization with continuous perfusion of pH 7.0 saline for ϳ30 min, the time was set as t ϭ 0. The duodenal loop was perfused with pH 7.0 saline from t ϭ 0 min until t ϭ 10 min (basal period). The perfusate was then changed to pH 7.0 Krebs buffer from t ϭ 10 min until t ϭ 35 min (challenge period), with or without chemicals. At t ϭ 10 min, the system was gently flushed so as to rapidly change the composition of the perfusate.
Experimental protocol. To examine the effect of luminal L-Glu on mucosal defense mechanisms, L-Glu (0.1-10 mM) was luminally perfused over the duodenal mucosa while pH i, blood flow, and MGT were measured. D-Glu (10 mM) was used as a negative control. In duodenal HCO 3 Ϫ secretion experiments, L-Glu (10 mM) was perfused through a duodenal loop during the challenge period.
Some animals were pretreated with high dose of capsaicin (125 mg/kg sc) 10 -14 days before the experiments to selectively denervate the afferent nerves or were pretreated with indomethacin (5 mg/kg ip) 1 h before the experiments to inhibit COX activity as previously described (6) . The duodenal mucosa of capsaicin-or indomethacintreated rats was superfused with L-Glu (10 mM) as described above.
To evaluate the involvement of T1Rs as an amino acid receptor in L-Glu effects, the effects of L-Asp, L-Ala, or L-Leu (each 10 mM) on pH i/blood flow/MGT or HCO 3 Ϫ secretion were examined. Because the luminal concentration of L-Ala (1.9 mM) or L-Leu (3 mM) in the human jejunum 3 h after a protein-rich meal is similar to that of L-Glu (2.6 mM) (1), we chose L-Ala and L-Leu in addition to another excitatory amino acid L-Asp to compare their effects with L-Glu. Because L-Glu-stimulated lingual umami perception is synergistically enhanced by the addition of IMP (41), and because the T1R1/T1R3 heterodimer is synergistically activated with amino acid ϩ IMP (32), the additional effect of IMP on mucosal defense factors (pH i/blood flow/MGT or HCO 3 Ϫ secretion) was examined. IMP (0.1 mM) alone or IMP with L-Glu, L-Asp, L-Ala, or L-Leu (each 10 mM) was superfused or perfused during the challenge period.
To test the role of mGluRs in L-Glu effects, we examined the effects of a selective group I mGluR (mGluR1 and 5) agonist S-DHPG (0.1 mM) or a selective group III mGluR (mGluR4, 6, 7, and 8) agonist L-AP4 (0.1 mM) on mucosal defense factors. The effects of coperfusion of a selective group I mGluR antagonist AIDA (0.1 mM) or a selective group III mGluR antagonist MAP4 (0.1 mM) with L-Glu (10 mM) were also examined. L-AP4 and MAP4 were predicted to be selective for mGluR4. Furthermore, a highly selective mGluR4 agonist was tested. VU0155041 (10 M), which is a potent allosteric modulator of mGluR4, but also acts as a highly selective allosteric agonist of mGluR4 (35) , was superfused.
To investigate the role of calcium-sensing receptor (CaSR) in L-Glu effects, the effects of perfusion of high Ca 2ϩ Krebs solution (4 mM) or a CaSR agonist spermine (1 mM) (16) on mucosal defense factors were examined.
Measurement of duodenal epithelial cell injury. Epithelial cellular injury was assessed by in vivo in situ PI staining as previously reported (4). The mucosa was superfused with a PI-containing Krebs solution (1 M) to stain injured cell nuclei. After BCECF images were captured, PI fluorescence was visualized by illuminating the mucosa at 535 nm with emission detected at 590 nm. PI-positive dots corresponding to injured cell nuclei were counted in each image (microscopic field) observed with ϫ10 objective lens. The mean of the number obtained from three microscopic fields was defined as the number for the given time period. We have correlated PI-positive cell number in vivo with a cellular injury scale on the basis of the examination of hematoxylin-eosin conventionally stained sections (4). After BCECF loading followed by the stabilization with pH 7.0 Krebs superfusion, the mucosa was superfused with pH 7.0 Krebs for 10 min with or without L-Glu (10 mM) during the basal period (t ϭ 0 -10 min), followed by superfusion of pH 1.8 acid solution for 5 min (challenge period, t ϭ 10 -15 min), then with pH 7.0 Krebs for 15 min (recovery period, t ϭ 15-30 min). PI images were captured every 5 min.
Expression of L-Glu receptors in rat tissues. To investigate the expression of L-Glu receptors in the rat tissues, RT-PCR analysis was performed for T1R isoforms, mGluR isoforms, and CaSR. Three rats were euthanized by the terminal exsanguinations under sodium pentobarbital anesthesia (50 mg/kg ip). The lower esophagus, fundus and antrum of stomach, proximal duodenum, Th1-Th8 dorsal root ganglia (DR), and nodose ganglia (NG) were removed and used for RT-PCR Fig. 3 . Effect of afferent denervation or cyclooxygenase inhibition on L-Gluinduced intracellular alkalinization and mucus secretion in rat duodenum. Rats were pretreated with capsaicin (Cap-t, 125 mg/kg sc) or indomethacin (Indo-t 5 mg/kg, sc). A: pHi. Cap-t and Indo-t inhibited L-Glu-induced intracellular alkalinization, while L-Glu acidified the cells in Cap-t rats. Each data point represents mean Ϯ SE (n ϭ 6 rats). *P Ͻ 0.05 vs. pH 7.0 Krebs group, †P Ͻ 0.05 vs. L-Glu group. B: mucus gel thickness. Cap-t and Indo-t reduced L-Glu-induced mucus secretion. Each data point represents mean Ϯ SE (n ϭ 6 rats). *P Ͻ 0.05 vs. pH 7.0 Krebs group, †P Ͻ 0.05 vs. L-Glu group. as previously described (5) . Furthermore, to sublocalize the presence of the target mRNA in the esophagus, stomach, and duodenum, these tissues were separated from the muscle layers and the mucosa by sharp dissection under a Zeiss stereomicroscope in ice-cold RNA stabilizing solution (RNA-Later; Qiagen, Valencia, CA) followed by RNA extract. The PCR primers used in the present study were listed in Table 1 , and ␤-actin was used as an internal control. An aliquot of the RT reaction product served as a template in 40 cycles with 30 s at 95°C, 30 s at 58 -64°C, and 30 s at 72°C. Furthermore, after dissection of villi, crypt, and muscle layer of the duodenum under a stereomicroscope, real-time PCR was performed with SYBR green fluorescence using a thermal cycler (MyiQ single-color real-time PCR detection system; Bio-Rad, Hercules, CA). Threshold cycle (Ct) value of each target mRNA was compared with Ct value of ␤-actin using ⌬Ct method for reference gene. The expression level of each receptor was presented as fold induction per 10 3 copies of ␤-actin. Each primer set showed 89 -98% PCR efficiency in brain or tongue tissue as positive controls, except for T1R2 (ϳ70%), presumably attributable to lower expression.
Statistics. All data are expressed as means Ϯ SE. Data were derived from six rats in each group. Comparisons between groups were made by one-way ANOVA followed by Fischer's leastsignificant difference test. P values of 0.05 were taken as significant.
RESULTS

Effect of luminal L-Glu on duodenal mucosal defense factors.
Duodenal perfusion with pH 7.0 Krebs buffer solution alone showed the stable pH i , MGT, and blood flow (Fig. 1,  A-C) . Luminal perfusion with L-Glu (0.1-10 mM) dose dependently increased pH i (Fig. 1A) . Luminal L-Glu also increased MGT, followed by the gradual decrease of gel thickness after L-Glu removal (Fig. 1B) , consistent with the increased mucus secretion (7) . In contrast, luminal L-Glu had no effect on blood flow (Fig. 1C) . These results suggest that luminal L-Glu enhances duodenal defense mechanisms.
Luminal perfusion of D-Glu or L-Asp (10 mM) had no effect on pH i or MGT in the duodenum (Fig. 2, A and B) . Furthermore, L-Ala or L-Leu (10 mM) also had no effect on pH i or MGT (Fig. 2, C and D) . None had any effect on blood flow. These results suggest that L-Glu is a potent effector on pH i and MGT.
Effect of capsaicin or indomethacin pretreatment on L-Gluinduced effects in rat duodenum. Because the duodenal mucosal defense mechanisms involve the activation of capsaicin-sensitive afferent nerves and/or COX (24), we next Ϫ secretion in rats. Duodenal HCO 3 Ϫ secretion is expressed as total CO2 output. Perfusion of L-Glu (10 mM) or IMP (0.1 mM) had a little effect on HCO 3 Ϫ secretion, while L-Glu coperfused with IMP synergistically augmented HCO 3 Ϫ secretion (A). Similar synergism was observed with perfusion of L-Asp (10 mM) (B) or L-Leu (10 mM) (D), whereas L-Ala (10 mM) increased HCO 3 Ϫ secretion without the synergy with IMP (C). Each data point represents mean Ϯ SE (n ϭ 6 rats). *P Ͻ 0.05 vs. pH 7.0 Krebs group, †P Ͻ 0.05 vs. the corresponding amino acid group. examined the effect of L-Glu on the duodenal mucosal defenses in capsaicin-or indomethacin-pretreated rats. Either treatment had no effect on pH i and MGT during the basal period (Fig. 3, A and B) . Pretreatment with indomethacin inhibited L-Glu-induced cellular alkalinization (Fig.  3A) and reduced L-Glu-induced mucus secretion (Fig. 3B) . Pretreatment with capsaicin actually decreased pH i during L-Glu perfusion (Fig. 3A) and reduced L-Glu-induced mucus secretion (Fig. 3B) . Blood flow was unchanged in any groups (data not shown). These results suggest that cellular alkalinization and mucus secretion induced by luminal LGlu are dependent on capsaicin-sensitive afferent nerves and COX activity in rat duodenum.
Expression of L-Glu receptors in the rat tissues. RT-PCR revealed high T1R1 and T1R3 expression in esophageal, gastric, and duodenal mucosa and in sensory neurons, with less T1R2 expressed (Fig. 4A ). mGluR1 and 4 and CaSR were also expressed in the fundic and duodenal mucosa. Furthermore, real-time PCR revealed that T1R1 and 3, mGluR1 and 4, and CaSR were expressed in the duodenal villi (Fig. 4B) .
Effect of luminal L-Glu on duodenal HCO 3 Ϫ secretion. Because HCO 3 Ϫ secretion is one of the most important, wellstudied defense factors against luminal acid in duodenum, we hypothesized that luminal L-Glu stimulates duodenal HCO 3 Ϫ secretion. Luminal perfusion of L-Glu (10 mM) significantly but slightly increased HCO 3 Ϫ secretion (Fig. 5A) , which was robustly enhanced by the addition of IMP (0.1 mM) to L-Glu. IMP alone had a little effect on HCO 3 Ϫ secretion. These results are consistent with the synergistic effect of L-Glu and IMP, well-described for L-Glu sensing by the taste buds (33) . Furthermore, L-Asp or L-Leu also modestly increased HCO 3 Ϫ secretion with robust enhancement by the addition of IMP (Fig.  5, B and D) , similar to L-Glu. These results suggest that L-Glu-associated HCO 3 Ϫ secretion is likely mediated via T1R1/ T1R3. In contrast, L-Ala alone increased HCO 3 Ϫ secretion without further significant enhancement by IMP (Fig. 5C) . Lack of synergy of L-Ala with IMP may be due to a different affinity for T1R1/T1R3 (32), submaximal effect of L-Ala alone, or a nonspecific effect.
The synergy between L-Glu and IMP prompted us to examine the effect of L-Glu and IMP on pH i and MGT. The addition of IMP inhibited L-Glu-induced cellular alkalinization (Fig. 6A) , suggesting that L-Glu-induced pH i modulation is closely linked with HCO 3 Ϫ secretion. The addition of IMP to L-Glu did not augment the peak value of MGT (Fig. 6B) . Nevertheless, the addition of IMP with L-Asp, L-Leu, or L-Ala had no effect on pH i , MGT, or blood flow (data not shown), further suggesting that the activation of T1R1/T1R3 does not directly affect pH i or MGT. Effect of mGluR agonists or antagonists on duodenal mucosal defense factors. Next, we examined the effect of mGluR agonists on pH i and MGT or the effect of mGluR antagonists on L-Glu-induced cellular alkalinization and mucus secretion in the duodenum. Perfusion of the mGluR4 agonist L-AP4 (0.1 mM) increased both pH i and MGT (Fig. 7, A and B) , mimicking the effects of L-Glu. In contrast, the mGluR1/5 agonist S-DHPG (0.1 mM) temporally increased pH i but had no effect on MGT (Fig. 7, A and B) . Coperfusion of the mGluR4 antagonist MAP4 (0.1 mM) with L-Glu abolished L-Glu-induced cellular alkalinization and inhibited L-Glu-induced mucus secretion, whereas the mGluR1/5 antagonist AIDA (0.1 mM) partially inhibited L-Glu-induced alkalinization but had no effect on L-Glu-induced mucus secretion (Fig. 7, D and E) . These results suggest that L-Glu-induced pH i and MGT increases are mediated mainly via mGluR4 and that mGluR1/5 is partially involved in only L-Glu-induced cellular alkalinization.
To further confirm the role of mGluR4 in L-Glu effects, we tested the highly selective compounds for mGluR4. Cells were alkalinized by a highly selective mGluR4 agonist VU0155041 (10 M) (Fig. 7A) . VU0155041 also stimulated mucus secretion (Fig. 7B) . Another highly selective mGluR4/8 agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (0.1 mM) also mimicked L-Glu effects on pH i and MGT (data not shown). These results further suggest that L-Glu increases pH i and MGT most likely via mGluR4.
We also tested the effects of the mGluR1/5 agonist S-DHPG (0.1 mM) or the mGluR4 agonist L-AP4 (0.1 mM) on duodenal HCO 3 Ϫ secretion. S-DHPG or L-AP4 had no effect on HCO 3 Ϫ secretion (Fig. 7C ), suggesting that, at least, mGluR1 and 4 were not involved in the regulation of duodenal HCO 3 Ϫ secretion.
Effect of CaSR agonists on duodenal mucosal defense factors. We next examined the effect of CaSR agonists on pH i , blood flow, and MGT. Perfusion of high Ca 2ϩ Krebs solution (4 mM) or spermine (1 mM) decreased pH i (Fig. 8A ) but increased MGT (Fig. 8B ) and blood flow (data not shown), mimicking the effect of luminal acid (2) but unlike L-Glu. Furthermore, perfusion of high Ca 2ϩ or spermine increased duodenal HCO 3 Ϫ secretion (Fig. 8C) . Effect of L-Glu on acid-induced epithelial injury in duodenum. Because luminal L-Glu enhanced mucosal defense mechanisms, we examined the protective effect of L-Glu on acidinduced injury. Acute epithelial injury was invoked in a microscopic model by perfusion of a superphysiological pH 1.8 acid solution for 5 min with injury measured in vivo in situ PI staining (4) . Exposure to a pH 1.8 solution progressively increased the number of PI-positive nuclei within the mucosa (Fig. 9) . Preperfusion of L-Glu (10 mM) reduced the increase of PI-positive nuclei, suggesting that luminal L-Glu protects the mucosa from acid-induced injury in the duodenum.
DISCUSSION
We demonstrated that luminal L-Glu increased pH i and MGT, but not blood flow, in the duodenal mucosa. L-Gluinduced cellular alkalinization and mucus secretion were mediated by capsaicin-and indomethacin-sensitive pathways in the duodenum, corresponding to the activation of capsaicinsensitive afferent nerves and COX activity, respectively. Lu- Fig. 7 . Effect of mGluR agonists or antagonists on duodenal mucosal defense factors. A and B: effects of (S)-3,5-dihydroxyphenylglycine (S-DHPG) (0.1 mM), L-2-amino-4-phosphonobutyric acid (L-AP4) (0.1 mM), or VU0155041 (10 M) on pHi of epithelial cells (A) and mucus gel thickness (B) were examined in rat duodenum. Each data point represents mean Ϯ SE (n ϭ 6 rats). *P Ͻ 0.05 vs. pH 7.0 Krebs group. C: duodenal loop was perfused, and HCO 3 Ϫ secretion was measured with pH and CO2 electrodes. HCO 3 Ϫ secretion is expressed as total CO2 output. Each data point represents mean Ϯ SE (n ϭ 6 rats). D and E: effects of 1-amino-2,3-dihydro-1H-indene-1,5-dicarboxylic acid (AIDA) (0.1 mM), or (S)-2-amino-2-methyl-4-phosphonobutyric acid (MAP4) (0.1 mM) on L-Glu (10 mM)-induced pHi (D) and mucus gel thickness (E) increases were examined. Each data point represents mean Ϯ SE (n ϭ 6 rats). *P Ͻ 0.05 vs. pH 7.0 Krebs group, †P Ͻ 0.05 vs. L-Glu group. minal L-Glu enhanced mucosal defense mechanisms via multiple L-Glu receptors (Fig. 10) . L-Glu-induced pH i and MGT increases were mimicked by mGluR4 agonists and inhibited by an mGluR4 antagonist. mGluR1/5 was partially involved in the L-Glu effect on pH i . In contrast, the synergy between L-Glu and IMP for augmentation of duodenal HCO 3 Ϫ secretion implicates the involvement of the T1R1/T1R3 heterodimer. This is the first study to demonstrate the involvement of L-Glu sensing by the upper GI mucosa in the enhancement of mucosal defense mechanisms and in the protection of the mucosa from acidinduced injury.
Cellular alkalinization is an important defense factor against luminal acid. Cellular alkalinization attributable to epithelial cell basolateral HCO 3 Ϫ uptake before HCO 3 Ϫ secretion protects the epithelial cells from acid-induced injury, as demonstrated using models of cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction (4, 8, 22) . We demonstrated that L-Glu-induced cellular alkalinization contributes to the protection of epithelial cells from acid-induced injury. Mucus secretion is another mucosal defense factor, which is thought to create a premucosal buffering zone, damping direct acid exposure to the epithelial cells (20) . Our study also implicates L-Glu-induced mucus secretion in the mucosal protection.
Mucosal defense mechanisms in the upper GI tract are mediated by capsaicin-sensitive afferent nerves and COX (24) . Capsaicin and PGE 2 stimulates HCO 3 Ϫ secretion with the augmented epithelial cellular buffering and stimulates mucus secretion in the duodenum (3, 42) , consistent with our result that L-Glu-induced increase of pH i and MGT was inhibited by pretreatment with capsaicin or indomethacin in the duodenum. These two pathways also increase blood flow in the duodenum (6, 27) , inconsistent with the observed lack of effect of L-Glu on blood flow. Because intracellular acidification, not alkalinization, is correlated with blood flow increase (9), L-Gluinduced cellular alkalinization may fail to increase blood flow, despite the involvement of capsaicin and COX pathways.
Possible candidates for the L-Glu receptor are taste receptor heterodimer (T1R1 and 3) (32, 48) or mGluR (1 or 4) (15, 44) , as reported in the taste buds for umami perception, or possibly the CaSR (17) . The T1R1/3 detects amino acids including L-Glu, L-Asp, L-Ala, and L-Leu with differing affinity synergistically enhanced by IMP (32) . The mGluR recognizes L-Glu selectively, yet synergism with IMP has not been confirmed. CaSR nonselectively binds L-type amino acids including L-Glu and L-Asp but is not synergistic with IMP (17) . The relatively specific effects of L-Glu on pH i and mucus secretion in the duodenum suggest that mGluRs are most likely L-Glu receptors. Our results suggest that mGluR4 mainly mediates L-Gluinduced pH i and MGT increases, whereas mGluR1 may have Ϫ secretion measured via duodenal loop perfusion was examined. Each data point represents mean Ϯ SE (n ϭ 6 rats). *P Ͻ 0.05 vs. pH 7.0 Krebs group. partial role in pH i regulation. In contrast, the synergistic effect of L-Glu, L-Asp, or L-Leu with IMP on duodenal HCO 3 Ϫ secretion suggests that T1R1/3 is the corresponding receptor. Nevertheless, L-Asp, L-Leu, or L-Ala alone had no effect on pH i and MGT, unlike L-Glu, suggesting that T1R1/3 is only involved in the regulation of HCO 3 Ϫ secretion. Furthermore, lack of effect of L-Asp, L-Leu, or L-Ala with IMP on pH i and MGT suggests that T1R1/3 activation is indirectly involved in pH i and MGT regulation. In contrast, CaSR agonists acidified cells and increased MGT, blood flow, and HCO 3 Ϫ secretion, like luminal acid, but unlike L-Glu. It is still possible that the CaSR is involved in L-Glu-induced mucus and HCO 3 Ϫ secretion. The selective inhibitors for T1R1/T1R3 and CaSR will clarify their contribution to L-Glu-induced augmentation in mucosal defense factors.
Inhibition of cellular alkalinization by L-Glu with IMP is still unclear. Because our results suggest that the modulation of pH i and HCO 3 Ϫ secretion by luminal L-Glu is differently mediated via mGluRs and T1Rs, respectively, the close link between pH i and HCO 3 Ϫ secretion may explain this phenomenon. A rapid increase in the rate of HCO 3 Ϫ secretion may reduce cellular HCO 3 Ϫ concentration, resulting the inhibition of cellular alkalinization. L-Glu and mGluR agonists had discrepant effects on pH i and HCO 3 Ϫ secretion. Although both agonists alkalinized cells, L-Glu increased HCO 3 Ϫ secretion, whereas mGluR agonists did not. Cellular alkalinization may not have been of sufficient magnitude to support measurable HCO 3 Ϫ secretion, which may also need the participation of other secretory components such as CFTR (4) . The mechanism by which CaSR stimulation acidified cells accompanied by increased mucus and HCO 3 Ϫ secretion is also unclear. Acid superfusion of the mucosa acidifies epithelial cells, presumably via CO 2 entry while increasing mucus secretion and blood flow (7) . Because CaSR activation produces comparable effects, we can speculate that the observed cellular acidification is attributable to augmented HCO 3 Ϫ secretion with reduction of cellular HCO 3 Ϫ concentration or to independent effects of CaSR activation. Activation of CaSR acidifies in vitro microperfused mouse medullary thick ascending limb cells, which express CaSR at the basolateral membrane (11), consistent with our finding. This suggests that intracellular acidification by CaSR activation triggers mucus and HCO 3 Ϫ secretion, similar to the effect of luminal acid.
L-Glu receptors have not been fully localized in the gut. Because intestinal endocrine cells as well as enterocytes are functionally implicated in luminal chemosensing (28, 29, 37, 38) , L-Glu receptors are likely to be expressed in the intestinal endocrine cells or enterocytes. Nevertheless, the localization of T1Rs in the GI tract is controversial. T1R1 and T1R3 are located on the apical membrane of rat jejunal enterocytes (28), whereas T1R3 is only expressed in the endocrine cells in human and mouse duodenum (29) . Although each expression was detected by PCR in this study, lack of specific antibodies for T1Rs limits to clearly localize T1Rs in the GI tract. In contrast, CaSR has been localized mainly on the basal surface of enterocytes, gastric surface cells, and parietal cells as well as in the myenteric plexus (14, 18, 39) . Furthermore, all groups of mGluRs are expressed in DR and NG (12, 13, 36) , suggesting the mGluR expression on the afferent nerves in the GI tract, consistent with our findings that L-Glu effects on pH i and MGT are mediated via mGluRs and capsaicin-sensitive afferent nerves. Detailed localization of these receptors in the GI tract may further clarify the mechanisms underlying L-Glu-induced effects on mucosal defense factors.
Luminal L-Glu signaling is of uncertain functional significance. Because L-Glu is the most predominant amino acid in proteins (21), a sharp rise of luminal L-Glu concentration can signal protein ingestion, readying the gut for gastric and pancreatic secretion of peptidases (45) . Although the luminal concentration of some other amino acids reached the similar level of L-Glu after a protein-rich meal in human jejunum (1), L-Asp, L-Ala, or L-Leu had no effect on pH i and MGT. The specificity for luminal L-Glu among the 20 amino acid in the stimulation of rat gastric vagal afferents accompanied by the release of 5-HT and nitric oxide (46) also support the observed protective effects of L-Glu on pH i and MGT. In contrast, these amino acids including L-Glu likely share the regulation of HCO 3 Ϫ secretion, suggesting cooperative mucosal protection during protein digestion. Because luminal L-Glu enhanced mucosal defenses and reduced acid-induced epithe- lial injury in the duodenum, luminal L-Glu signaling including L-Glu-specific and -nonspecific amino acid sensing may precondition or prime the mucosa for subsequent acid exposure and presumably protein digestion.
In conclusion, luminal L-Glu enhanced the mucosal defense mechanisms in the duodenum, via activation of most likely mGluR4 and T1R1/3, capsaicin-sensitive afferent nerves and COX pathway, protecting the mucosa from injury attributable to luminal acid. The umami taste receptors may be involved in the mucosal physiological responses for luminal amino acids, especially L-Glu.
